Instruments

Name Stock exchange Average volume Price Type
LEVI STRAUSS & CO. LEVI

Nyse +9 Other

1,461,579 24.16 USD Stock Levi Strauss & Co. Stock
LEVI STRAUSS & CO. LV2B

Deutsche Boerse AG

- 22.08 EUR Stock Levi Strauss & Co.
LEVI STRAUSS & CO. LV2B

Börse Stuttgart

- 22.07 EUR Stock Levi Strauss & Co.
LEVI STRAUSS & CO. LEVI

Wiener Boerse

50 22.04 EUR Stock Levi Strauss & Co.
LEVI STRAUSS & CO. 0A14

London S.E.

488 16.62 EUR Stock Levi Strauss & Co.
LEVI STRAUSS & CO. LEVI *

Mexican S.E.

444 406 MXN Stock Levi Strauss & Co.
LEVI STRAUSS & CO. LV2B

Frankfurt

188 18.7 EUR Stock Levi Strauss & Co.
LEVI STRAUSS & CO. LV2B

BOERSE MUENCHEN

145 22.12 EUR Stock Levi Strauss & Co.
LEVI STRAUSS & CO. 1LEVI

Borsa Italiana

52 22.18 EUR Stock Levi Strauss & Co.
LEVI STRAUSS & CO. LV2B

Berne S.E.

- - CHF Stock Levi Strauss & Co.
RAMI LEVI CHAIN STORES HASHIKMA MARKETING 2006 LTD RMLI

TEL AVIV STOCK EXCHANGE +1 Other

25,803 20,680 ILa Stock Rami Levi Chain Stores Hashikma Marketing 2006 Ltd Stock
RAMI LEVI CHAIN STORES HASHIKMA MARKETING 2006 LTD RLEVF

OTC Markets

135 67.95 USD Stock Rami Levi Chain Stores Hashikma Marketing 2006 Ltd
LEVI STRAUSS & CO. LV2C

BOERSE MUENCHEN

- 86.61 % Bond Levi Strauss & Co. Bond
LEVI STRAUSS & CO.

Deutsche Boerse AG

- 98.12 % Bond Levi Strauss & Co. Bond
LEVI STRAUSS & CO.

Deutsche Boerse AG

- 97.88 % Bond Levi Strauss & Co. Bond
LEVI STRAUSS & CO.

BOERSE MUENCHEN

- 98.22 % Bond Levi Strauss & Co. Bond
LEVI STRAUSS & CO. LV2C

Börse Stuttgart

- 86.58 % Bond Levi Strauss & Co. Bond
LEVI STRAUSS & CO.

Börse Stuttgart

- 97.39 % Bond Levi Strauss & Co. Bond
LEVI STRAUSS & CO.

BOERSE MUENCHEN

- 98.29 % Bond Levi Strauss & Co. Bond
LEVI STRAUSS & CO. LV2C

Deutsche Boerse AG

- 85.83 % Bond Levi Strauss & Co. Bond

News (731)

FDA Grants Priority Review to Genentech’s Inavolisib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation BU
FDA grants Priority Review to Roche’s inavolisib for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation GL
FDA Grants Breakthrough Therapy Designation to Genentech’s Inavolisib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer with a PIK3CA Mutation BU
FDA grants Breakthrough Therapy Designation to Roche’s inavolisib for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation GL
Roche Shares Climb After Weight-Loss Drug Shows Efficacy in Early-Stage Trial -- Update DJ
Roche Shares Climb After Weight-Loss Drug Shows Efficacy in Early-Stage Trial DJ
Genentech Reports Positive Phase Ib Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People With Obesity BU
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports positive Phase I results for its dual GLP-1/GIP receptor agonist CT-388 in people with obesity GL
Roche: positive CHMP opinion for Alecensa CF
FDA approves Roche’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer GL
FDA Approves Genentech's Alecensa as First Adjuvant Treatment for People With ALK-Positive Early-Stage Lung Cancer BU
Genentech’s Subcutaneous Ocrevus One-Year Data Demonstrates Near-Complete Suppression of Clinical Relapses and Brain Lesions in Patients With Progressive and Relapsing Forms of MS BU
Roche’s subcutaneous OCREVUS one-year data demonstrates near-complete suppression of clinical relapses and brain lesions in patients with progressive and relapsing forms of MS GL
Genentech’s Columvi Meets Primary Endpoint of Overall Survival in People With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Phase III STARGLO Study BU
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s Columvi meets primary endpoint of overall survival in people with relapsed or refractory diffuse large B-cell lymphoma in Phase III STARGLO study GL
Roche and Alnylam present positive results from the Phase II KARDIA-2 study of zilebesiran added to standard of care antihypertensives in patients with inadequately controlled hypertension AQ
Roche and Alnylam report positive topline results from the Phase II KARDIA-2 study in people with hypertension, demonstrating clinically significant blood pressure AQ
Roche and Alnylam report positive topline results from the Phase II KARDIA-2 study in people with hypertension, demonstrating clinically significant blood pressure reductions with zilebesiran when added to standard of care GL
New England Journal of Medicine Publishes Phase III Data Showing Xolair Significantly Reduced Allergic Reactions Across Multiple Foods in People With Food Allergies BU
New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies GL
FDA approves Xolair as first and only medicine for children and adults with one or more food allergies AQ
Roche: FDA approves allergy treatment CF
FDA approves Xolair as first and only medicine for children and adults with one or more food allergies GL
FDA Approves Xolair as First and Only Medicine for Children and Adults With One or More Food Allergies BU
New long-term data for Roche's Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO) AQ
New Long-Term Data for Genentech’s Vabysmo Show Sustained Retinal Drying and Vision Improvements in Retinal Vein Occlusion (RVO) BU
New long-term data for Roche’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO) GL
Roche cancer immunotherapy receives new EU approval AQ
European Commission approves Roche’s Tecentriq SC, the EU's first PD-(L)1 cancer immunotherapy subcutaneous injection for multiple cancer types GL
FDA grants priority review to omalizumab for food allergies AQ
Roche - FDA grants priority review to Xolair for children and adults with food allergies based on positive National Institutes of Health phase III study results AQ
Roche's Xolair Granted FDA Priority Review DJ
FDA grants priority review to Xolair (omalizumab) for children and adults with food allergies based on positive National Institutes of Health phase III study results GL
FDA Grants Priority Review to Xolair (omalizumab) for Children and Adults With Food Allergies Based on Positive National Institutes of Health Phase III Study Results BU
New data for Roche s Columvi and Lunsumio presented at ASH 2023 support continued benefit for people with lymphoma AQ
New data for Roche’s Columvi and Lunsumio presented at ASH 2023 support continued benefit for people with lymphoma GL
New Data for Genentech’s Columvi and Lunsumio Presented at ASH 2023 Support Continued Benefit for People With Lymphoma BU
New data reinforce the benefit of early preventative treatment with Roche’s Hemlibra for babies with severe haemophilia A AQ
New Data Reinforce the Benefit of Early Preventative Treatment With Genentech’s Hemlibra (emicizumab-kxwh) for Babies With Severe hemophilia A BU
New data reinforce the benefit of early preventative treatment with Roche’s Hemlibra for babies with severe haemophilia A GL
Roche's Inavolisib Breast Cancer Drug Gets Positive Results DJ
Roche: positive data for Kadcyla in breast cancer CF
Roche's Kadcyla is the first targeted therapy to show significant overall survival benefit in people with HER2-positive early-stage breast cancer with residual invasive disease after neoadjuvant treatment GL
Roche’s inavolisib combination reduces the risk of disease progression by 57% in people with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation GL
Genentech’s Kadcyla Is the First Targeted Therapy to Show Significant Overall Survival Benefit in People With HER2-Positive Early-Stage Breast Cancer With Residual Invasive Disease After Neoadjuvant Treatment BU
1234NextSee all

Companies (17)

SHANGHAI PUDONG DEVELOPMENT BANK CO., LTD. 33 802 M $
Logo Shanghai Pudong Development Bank Co., Ltd.

Shanghai Pudong Development Bank Co., Ltd. is a commercial bank. The group specializes in commercial loans and public deposits levying. At the end of 2020, Shanghai Pudong Development Bank manages CNY 4,122.4 billion of current deposits and CNY 4,430.2 b ...

LEVI STRAUSS & CO. 9 557 M $
Logo Levi Strauss & Co.

Levi Strauss & Co. is an apparel company. The Company designs and markets jeans, casual wear and related accessories for men, women and children under the Levi's, Signatureby Levi Strauss & Co., Denizen, Dockers and Beyond Yoga brands. The Company operate ...

RAMI LEVI CHAIN STORES HASHIKMA MARKETING 2006 LTD 775 M $
Logo Rami Levi Chain Stores Hashikma Marketing 2006 Ltd

Rami Levi Chain Stores Hashikma Marketing 2006 Ltd. is an Israel-based discount chain store which operates 14 branches in Jerusalem as well as in the surrounding areas of Shilat (Modiin), Mishor Adomim, Mevaseret Zion and Shaar Benyamin. The Company opera ...

SUN HING VISION GROUP HOLDINGS LIMITED 24 M $
Logo Sun Hing Vision Group Holdings Limited

Sun Hing Vision Group Holdings Limited is a Hong Kong-based investment holding company principally engaged in glasses-related businesses. The main businesses of the Company include the design, manufacture and sales of glasses and other related eyewear pro ...

CRYSTAL INTERNATIONAL GROUP LIMITED 1 638 M $
Logo Crystal International Group Limited

Crystal International Group Limited is a company principally engaged in the manufacture and distribution of clothes. The Company’s Products are divided into five categories, namely casual wear, personal underwear, sweaters and sportswear and outdoor clo ...

HYBRID FINANCIAL SERVICES LIMITED 4 M $
Logo Hybrid Financial Services Limited

Hybrid Financial Services Limited is an India-based company. The Company is engaged in the business activities of management consulting, which consists of debt recovery advise, consultancy in financial, secretarial, commercial, legal, direct and indirect ...

CREDO BRANDS MARKETING LIMITED 125 M $
Logo Credo Brands Marketing Limited

Credo Brands Marketing Ltd is an India-based company, which is engaged in in the business of selling of fashion casual garments and accessories under the brand name MUFTI. The Company operates in the men’s casual wear and apparels business segment. Its ...

PT MEGA PERINTIS TBK 58 M $
Logo PT Mega Perintis Tbk

PT Mega Perintis Tbk is an Indonesia-based apparel company. The Company is engaged in retail trading of apparels with a focus on men’s fashion. The Company operates under various brands, namely MANZONE that offers men’s apparel; MOC offers contemporar ...

NICHOLS PLC 479 M $
Logo Nichols plc

Nichols plc is an international soft drinks company. The Company is engaged in the supply of soft drinks to the retail, wholesale, catering, licensed and leisure industries. It has sales in over 73 countries, selling products in both the Still and Carbona ...

WA KAOLIN LIMITED 14 M $
Logo WA Kaolin Limited

WA Kaolin Limited is an Australia-based mineral exploration, extraction and processing company. The Company's principal activities are the exploration and development of an inferred mineral resource of high-grade premium kaolinized granite, proprietary pr ...

SOLIDUS COMMUNICATIONS INC. 422 009 $
Logo Solidus Communications Inc.

Solidus Communications, Inc. is specializing in the acquisition of technology infrastructure companies, comprised of Advanced Satellite Systems, Inc. and WiFIBER CORP. Advanced Satellite Systems, Inc. is a provider of Internet and television services to h ...

JAMAICA BROILERS GROUP LIMITED 216 M $
Logo Jamaica Broilers Group Limited

Jamaica Broilers Group Limited is a Jamaica-based company. The principal activities of the Company and its subsidiaries include the production and distribution of poultry products, animal feeds and agricultural items. The Company operates through three se ...

GENESCO INC. 332 M $
Logo Genesco Inc.

Genesco Inc. is a retailer and wholesaler of branded footwear, apparel and accessories. The Company’s segments include Journeys Group, Schuh Group, Johnston & Murphy Group and Genesco Brands Group. The Journeys Group segment comprises the Journeys, Jour ...

TILLY'S, INC. 173 M $
Logo Tilly's, Inc.

Tilly's, Inc. is a specialty retailer of casual apparel, footwear, accessories, and hardgoods for young men, young women, boys and girls. The Company’s stores are located in a variety of retail centers, including malls, lifestyle centers, power centers, ...

VARTEKS D.D. 872 215 $
Logo Varteks d.d.

Varteks dd is a Croatia-based textiles and clothes producer. It is principally engaged in the manufacture and sale of fabrics and garments, as well as trading with clothes and accessories. The Company exports its products to over 30 countries worldwide. T ...

THE BUCKLE, INC. 1 932 M $
Logo The Buckle, Inc.

The Buckle, Inc. is a retailer of casual apparel, footwear, and accessories. The Company operates approximately 440 retail stores in 42 states. The Company markets a wide selection of casual apparel including denim, other casual bottoms, tops, sportswear, ...

SEARS HOLDINGS CORPORATION 11 M $
Logo Sears Holdings Corporation

Sears Holdings Corp is a United States-based company. The Company is an integrated retailer with approximately 766 full-line and specialty retail stores. It operates through two segments: Kmart and Sears Domestic. Its Kmart segment offers a range of produ ...


12Next

Insiders

Picture Levi Garraway
Levi Garraway

Levi A.
Garraway
is the founder of Foundation Medicine, Inc. (founded in 2009) and Tango Therapeutics Sub, Inc. (founded in 2017).
He is currently the Director, Chief Medical Officer & Executive VP at Genentech, Inc. since 2019 and the Chief Medical Officer & Head-Product Development at Roche Holding AG.
Dr. Garraway's former positions include being the Director at the American Association for Cancer Research, Senior VP-Global Development & Medical Affairs at Eli Lilly & Co. from 2017 to 2019, and Assistant Professor at Dana-Farber Cancer Institute, Inc. from 2007 to 2011.


Picture Avi Levi
Avi Levi

Avi Levi is currently the Chief Executive Officer at Israel Discount Bank Ltd.
He previously served as the Chairman at IDB (Swiss) Bank Ltd.
and Discount Trust Ltd.
Mr. Levi received his undergraduate degree from Tel-Aviv University in 1991 and his MBA from Bar-Ilan University in 2005.


Picture Yaron Levi
Yaron Levi

Yaron R.
Levi
is currently the Chief Information Security Officer at Dolby Laboratories, Inc. He is also an Advisor at YL Ventures LLC, Safebreach, Inc., Capri Ventures LLC, Cyberstarts VC, and Silicon Valley CISO Investments.
In addition, he is an Advisor at Glilot Capital Investments GP Ltd.
and currently holds advisory positions at NTT Security AppSec Solutions, Inc., Optiv, Inc., and IntSights Cyber Intelligence Ltd.
Previously, he worked as the Director of Information Security at Cerner Corp., Director at TTI Telecom International Ltd., Principal & Information Security Business Partner at Intuit, Inc., and as a Member of the Board of Advisors at NTT Security AppSec Solutions, Inc., Optiv, Inc., and IntSights Cyber Intelligence Ltd.


Picture Pierre Levi
Pierre Levi

Pierre Levi is currently an Independent Director at Global Bioenergies SA, a Director at B Cell Design SAS, a Director at Rispa, and a Co-Manager at Metman Capital SARL.
Previously, he held positions such as Chairman & Chief Executive Officer at Forvia SE, Chief Executive Officer at Compagnie des Salins du Midi et des Salines de l'Est SASU, Deputy Chairman at Solvay France SA, and Deputy Chairman at Rhone-Poulenc SA. He also served as a Director at Ayming SAS, Kowee SA, and Vegetal SAS.
Mr. Levi received his undergraduate degree from École Nationale Supérieure des Mines de Paris and his MBA from The Wharton School of the University of Pennsylvania.


Picture Kate Garraway
Kate Garraway

Kate Garraway founded Fulfill Media Ltd.
in 2010, where she worked as Owner from 2010 to 2012.



Picture David A. Garraway
David A. Garraway

David A.
Garraway
currently works as a Director at Vroom Automotive Finance Corp.


Picture Elma Garraway
Elma Garraway

Elma Garraway currently works at Doctors Hospital Health System Ltd., as Director.


Picture Alvin R. Garraway
Alvin R. Garraway

Alvin R.
Garraway
is a Director of Valley Bancorp (Nevada) and a Member of the Nevada Society of CPAs and The American Institute of Certified Public Accountants.
Prior to joining Valley Bancorp (Nevada) in April 19, 2006, he was President and Controller of Oasis Residential, Inc. and an Audit Partner of Horwath Velez & Co. PSC.
He is a Certified Public Accountant.


Picture Richard Garraway
Richard Garraway

Richard Garraway is currently a Director at PBB Devices Ltd.
and a Director & Director-Intellectual Property at Ascension Healthcare Plc.
He was previously a Director at Novacta Biosystems Ltd., an Investment Banker at J.P.
Morgan & Co. Ltd., a Principal at Celtic Pharma Development UK Plc, and the Head-Business Development at Bedford Royalties Ltd.
Garraway holds an MBA and a doctorate from London Business School.













Picture John G. Levi
John G. Levi

John G.
Levi
is the founder of AMP Community.
He currently holds the position of Chairman at Legal Services Corp.
and Director at Chicago Child Care Society.


Picture Jeffrey Levi
Jeffrey Levi

Jeffrey Levi is currently the Director at The Trust for America's Health.
He has an undergraduate degree from Oberlin College, a graduate degree from Cornell University, and a doctorate from George Washington University.


Picture Uzi Levi
Uzi Levi

Uzi Levi worked as an Independent Director at Bank of Jerusalem Ltd.
from 2019 to 2020.
He also worked as an Executive Vice President-International Operations at Property & Building Corp.
Ltd.



Picture Levi Henrique
Levi Henrique

Levi Henrique is the founder of Geminids, which was founded in 1994.
He worked as a Managing Director at Eluma SA Indústria e Comércio from 1978 to 1984, as a Director at Cofap, and as an Independent Director at MRV Engenharia e Participaçoes SA. He also worked as a Managing Director at Lafonte Fechaduras SA from 1985 to 1986, at Metalpó Indústria e Comércio Ltda.
from 1987 to 1990, and at Protendit Industria E Comercio Ltda.
from 1990 to 1993.
Mr. Henrique obtained an undergraduate degree from Instituto Tecnológico de Aeronáutica.


Picture Mordechai Levi
Mordechai Levi

Mordechai Levi worked as a Vice President-Sales at Shaniv Paper Industry Ltd.



Picture Danny F. Levi
Danny F. Levi

Danny F.
Levi
is the founder of GetAFive, Inc. Prior to founding GetAFive, he worked at Yale University from 2004 to 2008.
He received his undergraduate degree from Yale University in 2008.






Picture Marco Levi
Marco Levi

Marco Levi is currently the Chief Executive Officer & Director at Ferroglobe PLC since 2020.
He is also the Chief Executive Officer at Thermission AG since 2019.
Additionally, he holds the position of Director at Ferroglobe Finance Co. PLC since 2021, Director at Euroalliages Aisbl since 2020, and Independent Director at Mativ Holdings, Inc. since 2017.
In his former positions, Dr. Levi served as the President & Chief Executive Officer at Ahlstrom Oyj from 2014 to 2016.
He was also the Director-Global Business Unit at The Dow Chemical Co. from 2006 to 2009.
Furthermore, he held the role of Independent Director at Schweitzer-Mauduit International, Inc. Dr. Levi's education includes an undergraduate degree from the University of Milan in 1984 and a doctorate degree from the same institution.



Picture Levi Spry
Levi Spry

Mr. Levi Spry is a Mining Analyst at UBS Securities Australia Ltd.
Mr. Spry was previously employed as a Senior Research Analyst by JCP Investment Partners Ltd., an Analyst by GMP Securities Australia Pty Ltd., a Research Analyst by Deutsche Bank AG (Australia), a Research Analyst by JPMorgan Securities Australia Ltd., and a Research Analyst by Patersons Securities Ltd.


Picture Bat-Sheva Levi
Bat-Sheva Levi

Bat-Sheva Levi formerly worked at Orbit Technologies Ltd., as Director and Visonic Ltd., as Non-Executive Director.
Ms. Levi received her graduate degree from Bar-Ilan University.






Picture Levi Kennedy
Levi Kennedy

Levi Kennedy was the founder of Signal Innovations Group, Inc. founded in 2004 where he held the title of Treasurer.
Currently, he holds the title of Senior Member at The Institute of Electrical & Electronics Engineers, Inc. and is a Member at Eta Kappa Nu.
Previously, he held the title of Principal at Raytheon Missile Systems Co. Mr. Kennedy has an undergraduate degree from Brigham Young University and a graduate degree from North Carolina State University.



Picture Levi Ravina
Levi Ravina

Mr. Levi Ravina is Controller at RAPAC Communication & Infrastructure Ltd.







Picture Stuart D. Levi
Stuart D. Levi

Stuart D.
Levi
is associated with Skadden, Arps, Slate, Meagher & Flom LLP since 2004 as a Partner.





Picture Levi Dow
Levi Dow

Levi Dow currently holds a position as Chief Operating Officer & Vice President at Wrangell Seafoods, Inc.












Picture Esther Levi
Esther Levi

Esther Levi is currently an Independent External Director at Nissan Medical Industries Ltd., a Director at Akum Ltd., an Independent External Director at Ten - Petroleum Co. Ltd., and an Independent Director at Automatic Bank Services Ltd.
She has an undergraduate degree and an MBA from Tel-Aviv University.





Picture Hila Levi
Hila Levi

Hila Levi worked as an Accountant at I.E.S Holdings Ltd.
from 2018 to 2019 and also worked as an Accountant at Ratio Energies LP.
Levi received an undergraduate degree from The College of Management Academic Studies.




Picture Levi Malik
Levi Malik

Levi Malik is a Principal on the private equity team.
Levi joined Viking in 2021 as a summer intern and rejoined full time in 2022.
Prior to joining Viking, Levi was an Executive Director at Pharmaceutical Product Development, a Private Equity Associate at Hellman and Friedman, and an Investment Banking Analyst at Morgan Stanley.
Levi received an MBA from the Stanford Graduate School of Business and a B.A.
in economics, summa cum laude, from Princeton University.



Picture Mary Levi
Mary Levi

Mary Levi currently works as a Director for the National Education Association.




Picture Amir Levi
Amir Levi

Amir Levi is currently the Managing Partner & Chief Executive Officer at Sphera Funds Management Ltd., the Chief Executive Officer at IBC Israel Broadband Co. (2013) Ltd., and the Director at Social Finance Israel.
He was previously a Director at Ayalon Insurance Co. Ltd.
Mr. Levi received his undergraduate and graduate degrees from The Hebrew University of Jerusalem.


Picture Benedetto Levi
Benedetto Levi

Benedetto Levi founded Extraverso in 2013.
Mr. Levi also currently works at Iliad Italia SpA, as Chief Executive Officer from 2018, Iliad Italia Holding SpA, as Chief Executive Officer, and Unieuro SpA, as Director.
Mr. Levi received his graduate degree from ESCP Europe Campus Paris and undergraduate degree from Politecnico di Torino.















Picture Levi Hong Kaye Lee
Levi Hong Kaye Lee

Dr. Levi H.
Lee, MD, is Independent Director at Immtech Pharmaceuticals, Inc. He is on the Board of Directors at Immtech Pharmaceuticals, Inc. and Immtech Hong Kong Ltd.
He received his undergraduate degree from the University of California, Berkeley and a doctorate degree from The University of California, San Francisco.


Picture Alan E. Levi
Alan E. Levi

Mr. Levi joined Alliance in 1973.
Prior to joining the Disciplined Growth Group in 1995, he held various responsibilities in the Equity Research Department as both an analyst and, between 1990-1995, as Director of Research.
He is a past Director and Treasurer of the Bank and Financial Analysts Association and served as a Director of the New York Society of Security Analysts between 1992-1994.
Mr. Levi received his undergraduate degree from Johns Hopkins and an M.B.A.
from the University of Chicago.



Picture Levi Manitsas
Levi Manitsas

Levi Manitsas currently works as a Director at Blue Mountain Hospital.





Picture Levi Roethler
Levi Roethler

Levi Roethler worked as a Junior Economist at Convex Capital Management LLC from 2016 to 2018.
He graduated from the University of Pittsburgh with a graduate degree in 2016 and from the University of Northern Iowa with an undergraduate degree.


No results for this search